Correlation Between NeoPharm and Korea New

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NeoPharm and Korea New at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeoPharm and Korea New into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeoPharm LTD and Korea New Network, you can compare the effects of market volatilities on NeoPharm and Korea New and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeoPharm with a short position of Korea New. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeoPharm and Korea New.

Diversification Opportunities for NeoPharm and Korea New

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between NeoPharm and Korea is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding NeoPharm LTD and Korea New Network in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Korea New Network and NeoPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeoPharm LTD are associated (or correlated) with Korea New. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Korea New Network has no effect on the direction of NeoPharm i.e., NeoPharm and Korea New go up and down completely randomly.

Pair Corralation between NeoPharm and Korea New

Assuming the 90 days trading horizon NeoPharm is expected to generate 2.66 times less return on investment than Korea New. In addition to that, NeoPharm is 1.22 times more volatile than Korea New Network. It trades about 0.05 of its total potential returns per unit of risk. Korea New Network is currently generating about 0.17 per unit of volatility. If you would invest  72,200  in Korea New Network on September 15, 2024 and sell it today you would earn a total of  17,800  from holding Korea New Network or generate 24.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NeoPharm LTD  vs.  Korea New Network

 Performance 
       Timeline  
NeoPharm LTD 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in NeoPharm LTD are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, NeoPharm may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Korea New Network 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Korea New Network are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Korea New sustained solid returns over the last few months and may actually be approaching a breakup point.

NeoPharm and Korea New Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NeoPharm and Korea New

The main advantage of trading using opposite NeoPharm and Korea New positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeoPharm position performs unexpectedly, Korea New can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korea New will offset losses from the drop in Korea New's long position.
The idea behind NeoPharm LTD and Korea New Network pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios